Angiodynamics Inc (ANGO) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2026, Angiodynamics reported revenue of $320.2M, up 9.5% from $292.5M the year before. Net income was -$36.7M (a -11.5% net margin), or -$0.88 per diluted share. Gross margin was 54.6% and operating margin was -12.5%. Operating activities generated $3.1M of cash, leaving $508,000 of free cash flow. At fiscal year end, Angiodynamics held $267.2M in total assets against $96.3M in total liabilities, including $53.9M of cash and equivalents.
Open the full interactive Angiodynamics financials → Quarterly statements, key ratios, valuation history and price charts.
Angiodynamics Key Stats
| Share Price | $10.90 |
|---|---|
| Market Cap | $458.0M |
| Revenue YoY Growth | +9.5% |
| 52-Week Range | $9.70 – $16.13 |
| Shares Outstanding | 42.0 million (basic, 2027 Q1) |
Angiodynamics Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $291.0M | $316.2M | $338.8M | $303.9M | $292.5M | $320.2M |
| Cost of Goods Sold | $134.2M | $150.5M | $164.5M | $149.2M | $134.8M | $145.3M |
| Gross Profit | $156.8M | $165.7M | $174.2M | $154.7M | $157.7M | $174.9M |
| Operating Income | -$35.3M | -$28.5M | -$51.2M | -$192.4M | -$40.0M | -$39.9M |
| Pre-Tax Income | -$36.1M | -$29.9M | -$54.4M | -$191.6M | -$34.0M | -$36.3M |
| Income Tax | -$4.5M | -$3.4M | -$2.0M | -$7.3M | -$39,000 | $442,000 |
| Net Income | -$31.5M | -$26.5M | -$52.4M | -$184.3M | -$34.0M | -$36.7M |
| Diluted EPS | -$0.82 | -$0.68 | -$1.33 | -$4.59 | -$0.83 | -$0.88 |
Angiodynamics Quarterly Results
| 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | |
|---|---|---|---|---|
| Revenue | $79.4M | $78.4M | $86.6M | $80.9M |
| Net Income | -$6.3M | -$8.1M | -$11.4M | -$7.1M |
| Diluted EPS | -$0.15 | -$0.19 | -$0.27 | -$0.17 |
Angiodynamics Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $48.2M | $28.8M | $44.6M | $76.1M | $55.9M | $53.9M |
| Current Assets | $140.9M | $143.3M | $163.5M | $193.3M | $168.3M | $163.4M |
| Total Assets | $561.4M | $552.8M | $532.6M | $317.7M | $280.1M | $267.2M |
| Current Liabilities | $57.6M | $74.3M | $83.8M | $91.2M | $76.2M | $74.7M |
| Total Long-Term Debt | $20.0M | $25.0M | $49.8M | — | — | — |
| Total Liabilities | $122.0M | $128.3M | $154.3M | $112.1M | $97.2M | $96.3M |
| Shareholders' Equity | $439.5M | $424.5M | $378.3M | $205.6M | $183.0M | $170.8M |
Angiodynamics Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $24.1M | -$7.2M | $78,000 | -$28.2M | -$10.1M | $3.1M |
| Cash From Investing | -$13.7M | -$19.3M | -$9.7M | $123.7M | -$10.2M | -$5.9M |
| Cash From Financing | -$17.0M | $7.7M | $25.4M | -$64.2M | -$255,000 | $564,000 |
| Free Cash Flow | $18.9M | -$11.5M | -$3.7M | -$30.7M | -$14.6M | $508,000 |
Figures from Angiodynamics' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Angiodynamics financials page for every line item.
Angiodynamics Company Profile
| Ticker | ANGO |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Latham, New York |
| Incorporated in | Delaware |
| Fiscal Year End | May 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001275187 |
Frequently Asked Questions
What was Angiodynamics' revenue in fiscal 2026?
Angiodynamics (ANGO) reported revenue of $320.2M for fiscal 2026.
What is Angiodynamics' annual revenue history?
Angiodynamics' annual revenue by fiscal year: 2021: $291.0M; 2022: $316.2M; 2023: $338.8M; 2024: $303.9M; 2025: $292.5M; 2026: $320.2M.
What was Angiodynamics' net income in fiscal 2026?
Angiodynamics reported net income of -$36.7M for fiscal 2026.
What was Angiodynamics' earnings per share (EPS) in fiscal 2026?
Angiodynamics' diluted EPS was -$0.88 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Angiodynamics generate in fiscal 2026?
Angiodynamics generated $508,000 of free cash flow in fiscal 2026.
What was Angiodynamics' revenue last quarter?
In its most recent reported quarter (2027 Q1), Angiodynamics reported revenue of $80.9M.
How many shares of Angiodynamics are outstanding?
Angiodynamics reported a weighted average of 42.0 million basic shares outstanding in 2027 Q1.
What is Angiodynamics' market cap?
Based on its latest closing price, Angiodynamics (ANGO) has a market capitalization of about $458.0M.
When does Angiodynamics' fiscal year end?
Angiodynamics' fiscal year end, as registered with the SEC, is May 31.
Where is Angiodynamics headquartered?
Angiodynamics lists its business address in Latham, New York in its SEC filings.
Angiodynamics Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →